• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

58-56-0 IC50

Mutations in nucleophosmin (exon 12 mutations in patients with AML using

August 4, 2017 by Katherine Lewis Leave a Comment

Mutations in nucleophosmin (exon 12 mutations in patients with AML using polymerase chain reaction amplification of genomic DNA followed by the analysis of amplification items by capillary electrophoresis. (AML) can be a heterogeneous disease medically, molecularly, and cytogenetically. Around 30% of instances display repeated cytogenetic abnormalities, reciprocal translocations typically, that assist define specific entities and … [Read more…]

Posted in: Blogging Tagged: 58-56-0 IC50, Rabbit polyclonal to PIWIL2

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by